Alyeska Investment Group’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-408,063	Closed	-$4.06M	–	784
2021 Q3	$4.06M	Buy	408,063 +84,000	+26%	+$835K	0.05%	371
2021 Q2	$3.2M	Buy	+324,063	New	+$3.2M	0.04%	431